WithdrawnPhase 2NCT01757899

Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children

Studying Pediatric acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidade Federal do Rio de Janeiro
Principal Investigator
Maria Clara M Barbosa
Instituto D'Or de Pesquisa
Intervention
Methylprednisolone Arm(drug)
Eligibility
17 years · All sexes
Timeline
20142016

Study locations (1)

Collaborators

Instituto de Puericultura e Pediatria Martagão Gesteira - IPPMG/UFRJ · Instituto D'Or de Pesquisa · Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01757899 on ClinicalTrials.gov

Other trials for Pediatric acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Pediatric acute respiratory distress syndrome

← Back to all trials